Education
About Us
Working with TipRanks
Follow Us
Sanofi (DE:SNW2)
FRANKFURT:SNW2
Total Valuation
Sanofi has a market cap or net worth of $116.81B. The enterprise value is €132.39B.
Market Cap$116.81B
Enterprise Value€132.39B
Share Statistics
Sanofi has 2,455,168,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,455,168,700
Owned by Insiders―
Owned by Institutions0.12%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.51%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.51%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee534.35K
Profits Per Employee66.31K
Employee Count82,878
Asset Turnover0.33
Inventory Turnover1.40
Valuation Ratios
The current PE Ratio of Sanofi is 20.97. Sanofi’s PEG ratio is 6.95.
PE Ratio20.97
PS Ratio0.00
PB Ratio1.50
Price to Fair Value1.50
Price to FCF19.80
Price to Operating Cash Flow12.84
PEG Ratio6.95
Income Statement
In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 2.22.
Revenue44.29B
Gross Profit31.08B
Operating Income7.25B
Pretax Income6.76B
Net Income5.56B
EBITDA11.03B
Earnings Per Share (EPS)2.22
Cash Flow
In the last 12 months, operating cash flow was 3.52B and capital expenditures -1.89B, giving a free cash flow of 1.59B billion.
Operating Cash Flow3.52B
Free Cash Flow1.59B
Free Cash Flow per Share0.65
Dividends & Yields
Sanofi pays an annual dividend of €1.303, resulting in a dividend yield of 2.71%
Dividend Per Share€1.303
Dividend Yield2.71%
Payout Ratio37.36%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change-0.87%
50-Day Moving Average50.00
200-Day Moving Average48.94
Relative Strength Index (RSI)50.86
Average Volume (3m)5.00
Important Dates
Sanofi upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateMay 09, 2025
Financial Position
Sanofi as a current ratio of 1.46, with Debt / Equity ratio of 28.41%
Current Ratio1.46
Quick Ratio1.14
Debt to Market Cap0.14
Net Debt to EBITDA0.95
Interest Coverage Ratio9.68
Taxes
In the past 12 months, Sanofi has paid 1.20B in taxes.
Income Tax1.20B
Effective Tax Rate0.18
Enterprise Valuation
Sanofi EV to EBITDA ratio is 6.23, with an EV/FCF ratio of 11.68.
EV to Sales1.55
EV to EBITDA6.23
EV to Free Cash Flow11.68
EV to Operating Cash Flow7.57
Balance Sheet
Sanofi has $7.99B in cash and marketable securities with €21.05B in debt, giving a net cash position of $13.06B billion.
Cash & Marketable Securities$7.99B
Total Debt€21.05B
Net Cash$13.06B
Net Cash Per Share$5.32
Tangible Book Value Per Share$9.46
Margins
Gross margin is 71.13%, with operating margin of 16.38%, and net profit margin of 12.55%.
Gross Margin71.13%
Operating Margin16.38%
Pretax Margin15.26%
Net Profit Margin12.55%
EBITDA Margin24.91%
EBIT Margin16.82%
Analyst Forecast
The average price target for Sanofi is $56.43, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$56.43
Price Target Upside18.54% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―